HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,169 | -17.8% | 35,685 | -11.7% | 0.06% | -11.3% |
Q2 2023 | $1,422 | +218.8% | 40,415 | +195.8% | 0.06% | +195.2% |
Q1 2023 | $446 | -53.4% | 13,665 | -21.4% | 0.02% | -60.4% |
Q4 2022 | $958 | -99.9% | 17,393 | +15.9% | 0.05% | +32.5% |
Q3 2022 | $664,000 | -10.9% | 15,003 | -1.8% | 0.04% | -28.6% |
Q2 2022 | $745,000 | -39.4% | 15,285 | -39.5% | 0.06% | -30.9% |
Q1 2022 | $1,230,000 | – | 25,281 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |